84 results
Page 2 of 5
8-K
EX-10.1
ltd9zbn
28 Jan 20
Entry into a Material Definitive Agreement
6:11am
8-K
EX-10.1
9p8zc
27 Jan 20
Nanoviricides Closes on $8.625 Million Underwritten Public Offering of Common Stock
5:12pm
8-K
EX-10.1
i4is6s
19 Dec 19
Entry into a Material Definitive Agreement
4:46pm
8-K
EX-10.2
amtb1zisx1
19 Dec 19
Entry into a Material Definitive Agreement
4:46pm
8-K
EX-10.3
rmed00t3y
19 Dec 19
Entry into a Material Definitive Agreement
4:46pm
8-K
EX-10.1
1p34ce32u3rvcir nw0
5 Nov 19
NanoViricides Completes Licensing for VZV Field which Includes Shingles Drug Development
9:39pm
S-1
EX-10.16
jjjrmaqhf5b ayrdqlu
28 Sep 19
IPO registration
3:07am
S-1
EX-10.7
v7d tz4jmigehr9qlm
28 Sep 19
IPO registration
3:07am
8-K
EX-10.1
3j0oboygz oex6mj29
10 Jun 19
Departure of Directors or Certain Officers
6:02am
8-K
EX-10.2
m80x5w6j6dv4dxac
1 Mar 19
NanoViricides Announces $2.5 Million Financing in a Registered Direct Offering
6:11am